Gilead Sciences Ordered to Pay $2.5 Billion in Damages to Merck & Co.

A federal jury in Delaware on Thursday ordered Gilead Sciences Inc. to pay $2.5 billion in damages to Merck & Co. for infringing its patents in developing hepatitis C drugs.

from WSJ.com: US Business http://ift.tt/2hTI33G
via IFTTT